Primary Biliary Cholangitis Trials in North Carolina

A listing of Primary Biliary Cholangitis Trials in North Carolina actively recruiting patient volunteers.

Search by Name
Search
Filter by Condition
Primary Biliary Cholangitis
4 trials found

Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Patients With PBC

NCT05239468

Study to determine the effect of the investigational drug bezafibrate (BZF) alone and in combination with the investigational drug obeticholic acid (also known as OCA) in patients with Primary Biliary Cholangitis (also known as PBC).

Conditions: Primary Biliary Cholangitis

Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis

NCT05133336

Saroglitazar Magnesium 1 mg and 2 mg tablets for treatment of subjects with Primary Biliary Cholangitis (PBC)

Conditions: Primary Biliary Cholangitis
Phase: Phase 2/3

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

NCT05104853

This study is a Phase 2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-104. The study consists of a 120 day primary study followed by a 20 month long-term safety and durability of response follow-up period.

Conditions: Primary Biliary Cholangitis
Phase: Phase 1/2

A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

NCT05014672

The primary objective of this study is to evaluate the effect of setanaxib on biochemical response at Week 52 in participants with primary biliary cholangitis (PBC) and with elevated liver stiffness and intolerance or inadequate response to ursodeoxycholic acid (UDCA).

Conditions: Primary Biliary Cholangitis, Liver Stiffness
Phase: Phase 2/3